Remove tag hcp
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

In this article Joanna Carlish, managing director of financial services at Tag Americas , and Robb DeFilippis, Tag Americas’ managing director, life sciences, go head-to-head to discuss marketing within a regulated industry. Joanna Carlish, managing director, financial services, Tag Americas. Virtual connections.

article thumbnail

Disruptive Tech in Pharma: A Future of Digital Interactions

Viseven

So HCP expectations from pharma companies are tenfold — “hey, give me something extremely personalized, do not actually bother me with an email chain, et cetera, which you think is right, but rather understand me better so that you can talk to me in a helping way.” If we take all the digital channels, how can you orchestrate them?

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top Commercial Benefits of Modular Approach

Viseven

Metadata tagging allows searching for a needed piece of delivery faster and easier than usual research on the content subject. A clearly defined initial thesis plus a unified design code make a perfect foothold to personalize it further, whether we are talking about a channel or HCP audience personalization.

article thumbnail

What is modular content and why do pharma marketers need it NOW?

pharmaphorum

Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.

article thumbnail

Insights From Medical Affairs Interactions

pharmaphorum

Is it possible to collate & synthesise such insights from all these Medical Affairs activities, in a way that enables you to see the truth that may be spread across many different KOL/HCP interactions? The short answer is “Sure!”. But a few things to consider when designing the process.

52